Intracranial haemorrhage in patients treated with direct oral anticoagulants

Thrombosis Research

Volumn 136, Issue 3, 2015, Pages 560-565

  Beynon, Christopher ^a   Sakowitz, Oliver W ^a   Störzinger, Dominic ^a   Orakcioglu, Berk ^a   Radbruch, Alexander ^a   Potzy, Anna ^a   Unterberg, Andreas W ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Anticoagulation; Haemostasis; Intracerebral haemorrhage; Trauma

Indexed keywords

ANTICOAGULANT AGENT; CREATININE; DIRECT ORAL ANTICOAGULANT; PROTHROMBIN COMPLEX; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN HEMORRHAGE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROSURGERY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTE COUNT; AGE DISTRIBUTION; CHEMICALLY INDUCED; COMORBIDITY; EPIDEMIOLOGY; INCIDENCE; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGE DISTRIBUTION; AGED; ANTICOAGULANTS; CAUSALITY; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; INTRACRANIAL HEMORRHAGES; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84940438619     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.07.001     Document Type: Article

References (30)

1. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, and et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N. Engl. J. Med. 365 2011 883 891 10.1056/NEJMoa1009638
2. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, and et al. Dabigatran versus warfarin in patients with atrial fibrillation N. Engl. J. Med. 361 2009 1139 1151 10.1056/NEJMoa0905561
3. C.B. Granger, J.H. Alexander, J.J.V. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, and et al. Apixaban versus warfarin in patients with atrial fibrillation N. Engl. J. Med. 365 2011 981 992 10.1056/NEJMoa1107039
4. F. Rong, B. Jia, P. Huang, H.S. Lynn, and W. Zhang Safety of the direct-acting anticoagulants in patients with atrial fibrillation: a meta-analysis Thromb. Res. 2015 10.1016/j.thromres.2015.04.004
5. J. Beyer-Westendorf, K. Förster, S. Pannach, F. Ebertz, V. Gelbricht, C. Thieme, and et al. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry Blood 124 2014 955 962 10.1182/blood-2014-03-563577
6. D.J. Graham, M.E. Reichman, M. Wernecke, R. Zhang, M.R. Southworth, M. Levenson, and et al. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation Circulation 131 2015 157 164 10.1161/CIRCULATIONAHA.114.012061
7. M.W. Parra, L. Zucker, E.S. Johnson, D. Gullett, C. Avila, Z.A. Wichner, and et al. Dabigatran bleed risk with closed head injuries: are we prepared? J. Neurosurg. 119 2013 760 765 10.3171/2013.3.JNS12503
8. S.N. Wassef, T.J. Abel, A. Grossbach, S.V. Viljoen, A.W. Jackson, M.A. Howard 3rd, and et al. Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature Neurosurgery 73 2013 E368 E373 10.1227/01.neu.0000430763.95349.5f (discussion E373-4)
9. J.C. Purrucker, D. Capper, L. Behrens, and R. Veltkamp Secondary hematoma expansion in intracerebral hemorrhage during rivaroxaban therapy Am. J. Emerg. Med. 2014 10.1016/j.ajem.2014.01.042
10. H. Heidbuchel, P. Verhamme, M. Alings, M. Antz, W. Hacke, J. Oldgren, and et al. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary Eur. Heart J. 34 2013 2094 2106 10.1093/eurheartj/eht134
11. Y. Xu, A.M. Holbrook, C.S. Simpson, D. Dowlatshahi, and A.P. Johnson Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis CMAJ Open 1 2013 E115 E119 10.9778/cmajo.20130032
12. T.B. Larsen, L.H. Rasmussen, F. Skjøth, K.M. Due, T. Callréus, M. Rosenzweig, and et al. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study J. Am. Coll. Cardiol. 61 2013 2264 2273 10.1016/j.jacc.2013.03.020
13. P. Teddy, and G. Nair Anti-stroke prophylaxis - the ethics of collateral damage J. Clin. Neurosci. 19 2012 792 794 10.1016/j.jocn.2012.01.024
14. C. Beynon, A. Potzy, O. Sakowitz, and A.W. Unterberg Rivaroxaban and intracranial haemorrhage after mild traumatic brain injury: A dangerous combination? Clin. Neurol. Neurosurg. 136 2015 73 78 10.1016/j.clineuro.2015.05.035
15. A. Alonso, L.G.S. Bengtson, R.F. MacLehose, P.L. Lutsey, L.Y. Chen, and K. Lakshminarayan Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin Stroke 45 2014 2286 2291 10.1161/STROKEAHA.114.006016
16. J. Hagii, H. Tomita, N. Metoki, S. Saito, H. Shiroto, H. Hitomi, and et al. Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin Stroke 45 2014 2805 2807 10.1161/STROKEAHA.114.006661
17. R.G. Hart, H.-C. Diener, S. Yang, S.J. Connolly, L. Wallentin, P.A. Reilly, and et al. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial Stroke 43 2012 1511 1517 10.1161/STROKEAHA.112.650614
18. G.J. Hankey, S.R. Stevens, J.P. Piccini, Y. Lokhnygina, K.W. Mahaffey, J.L. Halperin, and et al. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation Stroke 45 2014 1304 1312 10.1161/STROKEAHA.113.004506
19. M. Jun, M.T. James, B.J. Manns, R.R. Quinn, P. Ravani, M. Tonelli, and et al. The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study BMJ 350 2015 h246 10.1136/bmj.h246
20. P. Harper, L. Young, and E. Merriman Bleeding risk with dabigatran in the frail elderly N. Engl. J. Med. 366 2012 864 866 10.1056/NEJMc1112874
21. M.K. Wychowski, and P.A. Kouides Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment Ann. Pharmacother. 46 2012 10.1345/aph.1Q747 (e10)
22. W. Pfeilschifter, S. Luger, R. Brunkhorst, E. Lindhoff-Last, and C. Foerch The gap between trial data and clinical practice - an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulation Cerebrovasc. Dis. 36 2013 115 119 10.1159/000352062
23. F. Moustafa, G. Milhaud, N. Dublanchet, A. Lebreton, F. Dutheil, and J. Schmidt Retrospective study about 73 consecutive patients treated by direct oral anticoagulant and admitted to an emergency room J. Mal. Vasc. 40 2015 1 9 10.1016/j.jmv.2014.12.001
24. I. Hernandez, S.H. Baik, A. Piñera, and Y. Zhang Risk of bleeding with dabigatran in atrial fibrillation JAMA Intern. Med. 175 2015 18 24 10.1001/jamainternmed.2014.5398
25. P. Sardar, S. Chatterjee, E. Herzog, R. Nairooz, D. Mukherjee, and J.L. Halperin Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials Can. J. Cardiol. 30 2014 888 897 10.1016/j.cjca.2014.04.015
26. J. Bouchard, M. Ghannoum, A. Bernier-Jean, D. Williamson, G. Kershaw, C. Weatherburn, and et al. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran Clin. Toxicol. (Phila.) 53 2015 156 163 10.3109/15563650.2015.1004580
27. D. Kubitza, M. Becka, W. Mueck, A. Halabi, H. Maatouk, N. Klause, and et al. Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor Br. J. Clin. Pharmacol. 70 2010 703 712 10.1111/j.1365-2125.2010.03753.x
28. J.B. Kuramatsu, S.T. Gerner, P.D. Schellinger, J. Glahn, M. Endres, J. Sobesky, and et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage JAMA 313 2015 824 836 10.1001/jama.2015.0846
29. C. Beynon, A. Potzy, A.W. Unterberg, and O.W. Sakowitz Emergency neurosurgical care in patients treated with apixaban: report of 2 cases Am. J. Emerg. Med. 2014 10.1016/j.ajem.2014.12.017
30. D. Suryanarayan, and S. Schulman Potential antidotes for reversal of old and new oral anticoagulants Thromb. Res. 133 Suppl. 2 2014 S158 S166 10.1016/S0049-3848(14)50026-6